Progyny (PGNY) Cash from Financing Activities (2018 - 2026)
Progyny's (PGNY) quarterly Cash from Financing Activities came in at -$32.9 million in Q2 2026, down 1312.37% year-over-year from $2.7 million in Q2 2025, and up 73.28% quarter-over-quarter from -$123.1 million in Q1 2026.
Analysis
Progyny (PGNY) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Progyny (PGNY) has reported Cash from Financing Activities for 9 consecutive years, with -$32.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 1312.37% year-over-year to -$32.9 million in Q2 2026; TTM through Jun 2026 was -$249.8 million, a 99.33% decrease from a year earlier, with the FY2025 full-year figure at -$99.4 million, up 67.94% from the prior year.
- Cash from Financing Activities was -$32.9 million for Q2 2026 at Progyny, up from -$123.1 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at -$1.2 million in Q3 2022 and troughed at -$162.8 million in Q2 2024.
- A 5-year average of -$32.5 million and a median of -$4.2 million in 2023 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities tumbled 8752.04% in 2024 and soared 98.57% in 2025, its largest moves.
- Over 5 years, Cash from Financing Activities stood at -$2.8 million in 2022, then tumbled by 80.37% to -$5.0 million in 2023, then tumbled by 1020.94% to -$56.3 million in 2024, then tumbled by 56.69% to -$88.3 million in 2025, then jumped by 62.73% to -$32.9 million in 2026.
- The last three Cash from Financing Activities figures came in at -$32.9 million (Q2 2026), -$123.1 million (Q1 2026), and -$88.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.63 Bn | 1.16 Bn | -270.19 Mn |
| 2 | RadNet | 5.98 Bn | 5.55 Bn | 88.08 Mn | 240.22 Mn |
| 3 | Concentra Group Holdings Parent | 4.52 Bn | 4.39 Bn | 192.10 Mn | -24.67 Mn |
| 4 | Privia Health | 2.51 Bn | 2.15 Bn | - | 3.04 Mn |
| 5 | Pediatrix Medical | 2.11 Bn | 1.70 Bn | - | -48.24 Mn |
| 6 | Progyny | 2.10 Bn | 1.86 Bn | 89.30 Mn | -32.89 Mn |
| 7 | Fresenius Medical Care AG | 2.07 Bn | 1.37 Bn | 1.52 Bn | -894.48 Mn |
| 8 | Surgery Partners | 1.73 Bn | 2.95 Bn | 622.10 Mn | -5.10 Mn |
| 9 | U S Physical Therapy | 1.23 Bn | 1.52 Bn | 41.94 Mn | -31.52 Mn |
| 10 | Starling Oncology | 699.26 Mn | 658.17 Mn | 27.17 Mn | -218,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.89 Mn |
| Mar 31, 2026 | -123.11 Mn |
| Dec 31, 2025 | -88.26 Mn |
| Sep 30, 2025 | -5.49 Mn |
| Jun 30, 2025 | -2.33 Mn |
| Mar 31, 2025 | -3.29 Mn |
| Dec 31, 2024 | -56.33 Mn |
| Sep 30, 2024 | -63.35 Mn |
| Jun 30, 2024 | -162.79 Mn |
| Mar 31, 2024 | -27.41 Mn |
| Dec 31, 2023 | -5.03 Mn |
| Sep 30, 2023 | -2.36 Mn |
| Jun 30, 2023 | -1.84 Mn |
| Mar 31, 2023 | -1.85 Mn |
| Dec 31, 2022 | -2.79 Mn |
| Sep 30, 2022 | -1.23 Mn |
| Jun 30, 2022 | -2.08 Mn |
| Mar 31, 2022 | -1.77 Mn |
| Dec 31, 2021 | -3.31 Mn |
| Sep 30, 2021 | -3.06 Mn |